1932

Abstract

Progress in the discovery of new antiviral medicines is tempered by the rapidity with which drug-resistant variants emerge. A review of the resistance-suppressing properties of four classes of antivirals is presented: influenza virus neuraminidase inhibitors, HIV protease inhibitors, antibodies, and protein-based fusion inhibitors. The analysis supports the hypothesis that the more similar the drug is to the target's natural ligands, the higher the barrier to resistance. However, other factors, such as entropy compensation and solvent anchoring, might also be exploited for improved drug design.

Keyword(s): antibodyHIVinfluenza
Loading

Article metrics loading...

/content/journals/10.1146/annurev.biochem.78.082207.084029
2009-07-07
2024-04-18
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.biochem.78.082207.084029
Loading
/content/journals/10.1146/annurev.biochem.78.082207.084029
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error